Featured

PubMed: September 2023Seizures are common in neonates, but there is substantial management variability. The Neonatal Task Force of the International League Against Epilepsy (ILAE) developed evidence-based recommendations about antiseizure medication (ASM) management in neonates in accordance with ILAE standards. Seizures are the most common neu...
Discontinuation of antiepileptic drugs (AEDs) in seizure-free patients is an important goal because of possible long-term side effects and the social stigma burden of epilepsy. The purpose of this study was to assess seizure recurrence risk after suspension of AEDs, to evaluate predictors for recurrence, and to investigate the recovery of seizu...
Seizures are the most common manifestation of neurological insult during the neonatal period. The most common cause of symptomatic neonatal seizures is hypoxic/ischemic encephalopathy (HIE) which affects approximately 1-2/100 live births.There are no evidence-based guidelines for the pharmacologic treatment of neonatal seizures and management...
The New England Journal of Medicine: Published on December, 2019Evidence supports the use of benzodiazepines as the initial treatment for status epilepticus; however, seizures do not respond to benzodiazepines in up to a third of patients. Of the three medications most commonly used to treat benzodiazepine-refractory status epilepticus — leveti...
Gliomas are the most common malignant primary brain tumors and treatment options are multimodal. Seizures are a well-recognized symptom in glioma patients and occur frequently, either as a presenting symptom or during the course of the disease. The incidence of seizures is higher in slow-growing tumors.Seizure control plays an important role in...
PubMed Central: Published on October 2019 Status epilepticus is most common in children younger than 5 years, with incidence between 10 and 60 per 100,000 populations. Convulsive status for 30 min leads to irreversible neuronal injury. TAKE HOME MESSAGE Established Status Epilepticus Treatment Trial proposed that 35%–45% of p...
American Epilepsy Society issues guideline and treatment algorithm for convulsive status epilepticus. The guideline was endorsed by the Epilepsy Foundation, Child Neurology Society, and American College of Emergency Physicians.Status epilepticus – continuous or rapid sequential seizure activity for 30 minutes or more – is a medical emergency wi...
JAMA: The Journal of the American Medical Association: Published on April 5, 2022 Epilepsy affects approximately 65 million people worldwide. Persistent seizures are associated with a 20% to 40% risk of bodily injuries (eg, fractures, burns, concussions) over 12-month follow-up. The primary goal of epilepsy treatment is to eliminate seiz...
The New England Journal of Medicine (NEJM): Published on July 15, 2021 The incidence rate of a single unprovoked seizure among adults is 23 to 61 cases per 100,000 person-years. After a first unprovoked seizure, the overall risk of recurrence may be as high as 60%, and this risk is highest within the first 2 years. Epilepsy is...
TAKE-HOME MESSAGE A systematic review of the literature published between January 1991 and March 2020 was used to update the 1996 American Academy of Neurology practice parameter that provided considerations for discontinuing antiseizure medications in affected patients.   The authors of this update developed 14 reco...